معرفی
François Gagnon is an Adjunct Research Professor at Carleton University’s School of Continuing Studies, affiliated with the Faculty of Engineering and Design. His work critically examines the pharmaceutical industry’s impact on public health, regulatory transparency, drug pricing, and corporate influence on biomedical research. His research spans topics including pharmacare policy, health equity, and the ethical implications of industry-funded clinical trials.
Key interests include analyzing how corporate interests shape health policies, drug access disparities, and the governance of chemical and pharmaceutical regulatory agencies. He frequently critiques the transparency of Health Canada’s oversight mechanisms and advocates for evidence-based approaches to healthcare policy reform.
His articles highlight tensions between public health needs and commercial interests, with recent works focusing on rare disease strategies, Glyphosate herbicide regulation, and improving transparency in drug manufacturer activities. Despite no listed awards, his prolific publications underscore his commitment to advancing accessible healthcare systems.
Gagnon has not disclosed advisees, though his research often collaborates with organizations advocating for pharmaceutical industry accountability. His work bridges academic research with real-world policy implications, emphasizing the need for systemic reforms in global health governance.
